Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Bayer describes novel PDE9A inhibitors for Alzheimer's disease

March 2, 2005

Eisai scientists disclose the neuroprotective activity of donepezil hydrochloride

March 2, 2005

Modulators of amyloid beta levels claimed by Neurogenetics for Alzheimer's disease

March 2, 2005

Extended treatment improves tacrolimus efficacy in myasthenia gravis

March 2, 2005

Chondroitinase shows promise in the management of spinal cord injuries

March 2, 2005

Allopurinol shows promise as add-on therapy for refractory schizophrenia

March 2, 2005

Tasmar receives European approval

March 2, 2005

MEM-3454 studied in phase I trial

March 2, 2005

Archimedes Pharma extends nasal drug delivery collaboration with Ionix

March 2, 2005

OX-22 completes efficacy study for insomnia

March 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026